- Organizations: LumiThera
Business
OpZira launches with LumiThera diagnostic product line
Spin-off company official forms following Alcon-LumiThera acquisition to offer two ophthalmic products: the AdaptDx Pro and NOVA Vision Testing System.
Business
Alcon officially purchases LumiThera
Acquisition of the Valeda Light Delivery System includes plans to expand commercial market availability in 2026.Business
Alcon to purchase LumiThera
Targeting a Q3 sale, acquisition includes Valeda Light Delivery System, the first and only PBM treatment for early-to-intermediate dry AMD.
Research
LumiThera Valeda system extension trial data expands dry AMD vision improvements
Presented at ARVO, new findings support earlier initiation and extended vision benefits of Valeda Light Delivery System out to 4.5 years.Products
FDA grants authorization to LumiThera's Valeda system for dry AMD
Approval makes the photobiomodulation treatment the first device of its kind to treat vision loss among dry AMD patients.
Legal
LumiThera receives first CPT code for retina-based PBM therapy
New Category III code applies to the Valeda Light Delivery System, intended to treat dry AMD.
Pipeline
LumiThera submits FDA De Novo request for Valeda Light Delivery System
Pending potential acceptance, the photobiomodulation treatment system could be introduced into the U.S. market by mid-2024.
Research
LumiThera receives NIH grant for dry AMD extension trial
Funding will support an additional year of open-label study for LIGHTSITE III.
Pipeline